Hardeol Pharmaceuticals Private Limited
About Hardeol Pharmaceuticals Private Limited
Data last updated:
Hardeol Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 January 2023.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2023PTC170267. Its GSTIN is 32AAGCH6562H1ZL (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Abhijith Vattakkattu Ravi and Kasaragod Ganesha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹18.45 Lakh. For the same year it recorded a net loss of ₹1.21 Lakh (net margin -6.6%) and EBITDA of -₹92,885 (EBITDA margin -5%).
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB – 821 Kalkere, Cumins Genesis Apt, Bangalore, Karnataka, India – 560043
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Hardeol Pharmaceuticals Private Limited
The main business activity of Hardeol Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Hardeol Pharmaceuticals Private Limited FY 2025 filings available
Hardeol Pharmaceuticals Private Limited reported revenue of ₹18.45 Lakh for FY 2024.
Financial Statement Summary of Hardeol Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹92,885 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹1.21 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Hardeol Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -5% | •••• |
| Net Profit Margin | -6.6% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hardeol Pharmaceuticals are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Hardeol Pharmaceuticals Private Limited
Hardeol Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Natural Solutions and Neutraceuticals Private Limited | ₹18.56 Lakh (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Vidacare Pharmaceuticals Private Limited | ₹18.54 Lakh (FY 2019) | •••• | •••• | -61.0% | •••• | Ahmedabad, Gujarat, India |
| Motivi Pharmaceuticals Private Limited | ₹18.53 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Colvale, Goa, India |
| Aartha Pharmaceuticals Private Limited | ₹18.52 Lakh (FY 2024) | •••• | •••• | -18.0% | •••• | Hyderabad, Telangana, India |
| Kannikkatt Pharmaceuticals Private Limited | ₹18.49 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Kottayam, Kerala, India |
| Hardeol Pharmaceuticals Private Limited this company | ₹18.45 Lakh (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Nigpa Pharma Private Limited | ₹18.42 Lakh (FY 2016) | •••• | •••• | 15.0% | •••• | Aurangabad, Maharashtra, India |
| Oncecare Pharmaceuticals Private Limited | ₹18.41 Lakh (FY 2025) | •••• | •••• | 63.0% | •••• | Jamshedpur, Jharkhand, India |
| Kapkind Pharma Private Limited | ₹18.39 Lakh (FY 2023) | •••• | •••• | 13.0% | •••• | Lucknow, Uttar Pradesh, India |
| Leczen Pharmaceuticals Private Limited | ₹18.36 Lakh (FY 2025) | •••• | •••• | 21.0% | •••• | Muzaffarpur, Bihar, India |
| Chennai Ayurveda Pharmacy Private Limited | ₹18.34 Lakh (FY 2020) | •••• | •••• | 2.0% | •••• | Athipet Ambathur, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Hardeol Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Hardeol Pharmaceuticals Private Limited
Hardeol Pharmaceuticals has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhijith Vattakkattu Ravi | Director | 12 Jan 2023 | 3 Years 9 Months | Current |
| Kasaragod Ganesha | Director | 12 Jan 2023 | 3 Years 9 Months | Current |
| Kondattil Krishnadasan | Director | 12 Jan 2023 | 3 Years 9 Months | Current |
| Thalakkale Veettil Mini | Director | 12 Jan 2023 | 3 Years 9 Months | Current |
| Kallam Parambil Sujith | Director | 27 Mar 2023 | 3 Years 6 Months | Current |
Charges & Borrowings of Hardeol Pharmaceuticals Private Limited
Hardeol Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Hardeol Pharmaceuticals Private Limited
Hardeol Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Glaxosmithkline Pharmaceuticals Limited | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Hardeol Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Hardeol Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Hardeol Pharmaceuticals Private Limited
Hardeol Pharmaceuticals Private Limited has 5 board changes on record since 2023: 5 appointments. The latest: Kallam Parambil Sujith was appointed as Director on 27 Mar 2023.
Credit Ratings, Litigation & Regulatory Alerts for Hardeol Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hardeol Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hardeol Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hardeol Pharmaceuticals Private Limited
Hardeol Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAGCH6562H1ZL | Kerala | Active | 01 Feb 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hardeol Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hardeol Pharmaceuticals Private Limited
Hardeol Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 January 2023 (3+ years old) and is registered under CIN U24290KA2023PTC170267.
Hardeol Pharmaceuticals reported revenue of ₹18.45 Lakh for FY 2024.
Hardeol Pharmaceuticals has 5 current directors:
- Abhijith Vattakkattu Ravi - Director
- Kasaragod Ganesha - Director
- Kondattil Krishnadasan - Director
- Thalakkale Veettil Mini - Director
- Kallam Parambil Sujith - Director
Hardeol Pharmaceuticals reported a net loss of ₹1.21 Lakh (net margin -6.6%) and EBITDA of -₹92,885 (EBITDA margin -5%) for FY 2024, as per its filed financial statements.
The GSTIN of Hardeol Pharmaceuticals is 32AAGCH6562H1ZL, registered in Kerala.
The CIN (Corporate Identification Number) of Hardeol Pharmaceuticals is U24290KA2023PTC170267. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hardeol Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Hardeol Pharmaceuticals was incorporated on 12 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Hardeol Pharmaceuticals by revenue are Natural Solutions and Neutraceuticals Private Limited, Vidacare Pharmaceuticals Private Limited, Motivi Pharmaceuticals Private Limited, Aartha Pharmaceuticals Private Limited, Kannikkatt Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Kallam Parambil Sujith was appointed as Director on 27 Mar 2023. Abhijith Vattakkattu Ravi was appointed as Director on 12 Jan 2023. Kasaragod Ganesha was appointed as Director on 12 Jan 2023. Hardeol Pharmaceuticals has 5 board changes on record in total.
The registered office of Hardeol Pharmaceuticals is at B – 821 Kalkere, Cumins Genesis Apt, Bangalore, Karnataka, India – 560043.